Trump Reclassifies Marijuana, FDA Fast‑Tracks Devices
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Trump reclassifies state‑licensed medical marijuana from Schedule I to Schedule III, easing research and prescription rules.
- CMS and FDA launch a Medicare coverage pathway that aligns FDA pre‑market approval with Medicare reimbursement for breakthrough devices.
- Anil reports that cancer cells spread rapidly in transplanted mouse hearts with lower mechanical stress, while native hearts remained largely resistant.
Why it matters: Not enough in the article to say why this matters.
